Hologic (HOLX) Tops Q3 EPS by 37c, Revenues Beat; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Hologic Announces Financial Results for Third Quarter of Fiscal 2020
July 29, 2020 4:01 PM EDTRevenue of $822.9 Million Declines 3.5% due to Cynosure Divestiture, 3.1% in Constant Currency
Organic Revenue Increases 7.7%, 8.1% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses
Company Posts GAAP Diluted EPS of $0.53, Non-GAAP Diluted EPS of $0.75
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Companys financial results for the fiscal third quarter ended June 27, 2020.
Our strong third quarter financial results reflect the incredible contributions the Hologic team is making in the fight against the... More
